Intech Investment Management LLC Lowers Stake in The Ensign Group, Inc. $ENSG

Intech Investment Management LLC reduced its position in The Ensign Group, Inc. (NASDAQ:ENSG) by 20.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,876 shares of the company’s stock after selling 5,609 shares during the quarter. Intech Investment Management LLC’s holdings in The Ensign Group were worth $3,780,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Steward Partners Investment Advisory LLC lifted its stake in shares of The Ensign Group by 638.7% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 229 shares of the company’s stock valued at $35,000 after buying an additional 198 shares in the last quarter. Root Financial Partners LLC purchased a new stake in The Ensign Group in the 3rd quarter worth $35,000. MAI Capital Management raised its holdings in The Ensign Group by 1,009.5% during the second quarter. MAI Capital Management now owns 233 shares of the company’s stock valued at $36,000 after acquiring an additional 212 shares during the period. Hantz Financial Services Inc. raised its holdings in The Ensign Group by 1,128.6% during the second quarter. Hantz Financial Services Inc. now owns 258 shares of the company’s stock valued at $40,000 after acquiring an additional 237 shares during the period. Finally, SBI Securities Co. Ltd. lifted its position in shares of The Ensign Group by 872.4% in the second quarter. SBI Securities Co. Ltd. now owns 282 shares of the company’s stock valued at $44,000 after acquiring an additional 253 shares in the last quarter. 96.12% of the stock is owned by hedge funds and other institutional investors.

The Ensign Group Stock Up 0.7%

Shares of ENSG opened at $214.17 on Monday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.42 and a quick ratio of 1.42. The stock has a market capitalization of $12.40 billion, a price-to-earnings ratio of 36.67, a price-to-earnings-growth ratio of 2.10 and a beta of 0.83. The Ensign Group, Inc. has a 1 year low of $118.73 and a 1 year high of $216.92. The business’s 50 day simple moving average is $187.39 and its 200-day simple moving average is $180.11.

The Ensign Group (NASDAQ:ENSG) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.07. The company had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.37 billion. The Ensign Group had a net margin of 6.80% and a return on equity of 16.76%. The Ensign Group’s quarterly revenue was up 20.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.49 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. As a group, equities analysts expect that The Ensign Group, Inc. will post 5.59 earnings per share for the current fiscal year.

The Ensign Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Saturday, January 31st. Stockholders of record on Wednesday, December 31st were issued a $0.065 dividend. This is a positive change from The Ensign Group’s previous quarterly dividend of $0.06. The ex-dividend date was Wednesday, December 31st. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.1%. The Ensign Group’s dividend payout ratio (DPR) is presently 4.45%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on ENSG shares. Truist Financial set a $215.00 target price on The Ensign Group and gave the stock a “hold” rating in a research report on Friday, February 6th. Zacks Research upgraded The Ensign Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday. UBS Group set a $230.00 price objective on shares of The Ensign Group and gave the company a “buy” rating in a report on Friday, February 6th. Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, Royal Bank Of Canada restated an “outperform” rating and set a $222.00 target price (up from $206.00) on shares of The Ensign Group in a research report on Monday, February 9th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, The Ensign Group currently has an average rating of “Buy” and a consensus price target of $204.60.

Insider Activity at The Ensign Group

In other The Ensign Group news, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $171.54, for a total transaction of $120,078.00. Following the transaction, the director owned 23,552 shares in the company, valued at $4,040,110.08. The trade was a 2.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Suzanne D. Snapper sold 8,258 shares of the stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $194.48, for a total transaction of $1,606,015.84. Following the completion of the sale, the chief financial officer directly owned 277,462 shares in the company, valued at $53,960,809.76. This trade represents a 2.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 26,773 shares of company stock valued at $5,018,308 over the last three months. Corporate insiders own 3.90% of the company’s stock.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.